News
8h
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
The report emphasises the urgent need for countries to implement radical changes in their HIV programming and funding ...
23h
Korea JoongAng Daily on MSNUN warns millions will die by 2029 if U.S. funding for HIV programs isn't replacedYears of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results